Welcome Message from the Conference Chair
“We’re going to tell our grandchildren and great-grandchildren that we were there at the time these incredible advances in the care of patients with aortic stenosis were presented.”
Ever since the first percutaneous mitral commissurotomy by transseptal technique was performed in Lebanon in 1993, the treatment of valvular heart disease has undergone drastic changes. New innovative approaches to patient care in cardiology have made our daily life in the cath lab a thrilling journey, full of challenges and achievements:
- 2012 TAVI
- 2015 Mitraclip
- 2017 Para-Valvular Leak Closure
- 2018 TMVI
And the journey continues: Tricuspid clip, cardioband, chordae implantation…
Our expertise is growing, and so should our collaboration.
In our symposium on October 26, 2019 we’ll be discussing these moving frontiers, and more. We’ll also be tackling a neglected chapter, at least in Lebanon, on coronary plaque imaging and remodeling.
International and Lebanese experts in the field will be taking part in sessions dedicated to aortic, mitral and right heart valves, and will examine evolving techniques, expanding indications and innovations in treating coronary plaque.
I’m very pleased to have the unwavering support of our partners in the industry; their presence beside us shows the extent of their commitment to spreading their knowledge and putting Lebanese interventional cardiology at the cutting edge of trans-catheter therapeutics.
I am sure that your participation in this symposium will set the pace for a new phase of collaboration between all Lebanese interventionists, whose duty it is to guide future generations.
It’ll be a step forward in our 1000 miles journey of Innovations in Interventions where each and every one of us will have an impact.
Welcome to the first LAU Symposium on Heart Disease.
Georges Ghanem MD, FESC, FACC
Chief Medical Officer
LAU Medical Center-Rizk Hospital
Professor of Cardiology
LAU Gilbert and Rose-Marie Chagoury School of Medicine